文献速递中医内科中药与中成药合理使用

中药调控铁死亡治疗胃癌的药理机制综述

Pharmacological mechanisms of traditional Chinese medicine in treating gastric cancer: a focus on the ferroptosis regulation.
PubMed 文献 · Front Pharmacol · 2026-01-26

该综述系统检索PubMed、Web of Science、Scopus和ISI数据库,汇总中药通过调控铁死亡治疗胃癌的现有文献。文章指出中药可诱导胃癌细胞铁死亡、抑制肿瘤增殖,并增强放疗、靶向治疗和免疫治疗疗效,为铁死亡靶向中药干预策略提供理论基础。

要点

  • 中药可通过调控铁死亡诱导胃癌细胞死亡并抑制肿瘤增殖。
  • 中药调控铁死亡可增强放疗、靶向治疗和免疫治疗的疗效。
  • 铁死亡靶向中药为胃癌精准诊疗和临床防治提供新思路。

核心结论

  • 靶向铁死亡的中药在胃癌治疗中具有潜力,为阐明胃癌发病机制和建立铁死亡靶向中药干预策略奠定理论基础。

研究设计与样本

  • 综述类研究,系统检索PubMed、Web of Science、Scopus和ISI数据库,检索关键词包括胃癌/肿瘤、天然产物、天然提取物、中药提取物、中药方剂和铁死亡。

主要发现

  • 中药不仅诱导肿瘤细胞铁死亡并抑制肿瘤增殖,还增强放疗、靶向治疗和免疫治疗的疗效,从而改善整体治疗效果。

临床怎么用

  • 中药调控铁死亡可作为胃癌治疗的潜在策略,并可能作为放疗、靶向治疗和免疫治疗的增效手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In recent years, the incidence and mortality rates of gastric cancer (GC) have continued to rise, making it a major public health concern that poses a severe threat to human health. Although significant progress has been made in the treatment of GC in recent years, the overall median survival time for patients remains short. This situation is primarily attributed to the high metastatic potential and recurrence rate of tumors, as well as the generally low sensitivity of patients to radiotherapy and chemotherapy. Therefore, the development of safe, effective, and sustainable therapeutic strategies has become an urgent and critical issue in global medical research. Chinese herbal medicine, with its unique advantages such as low cost, minimal risk of drug resistance, and fewer adverse effects, has accumulated extensive clinical experience in the treatment of GC, demonstrating broad application prospects. METHODS: We systematically searched databases including PubMed, Web of Science, Scopus, and ISI using the following keywords: "gastric cancer/tumor," "natural products," "natural extracts," "traditional Chinese medicine extracts," "traditional Chinese medicine formulas," and "ferroptosis." A comprehensive review and analysis of the existing relevant literature were conducted. RESULTS: Currently, the management of gastric cancer (GC) primarily relies on surgical resection, complemented by a range of therapeutic modalities including radiotherapy, chemotherapy, targeted therapy, and immunotherapy. However, the overall median survival rate for patients with GC remains unsatisfactory. In recent years, accumulating evidence has indicated that Chinese herbal medicine may play a significant role in the treatment of GC through the regulation of ferroptosis. Emerging studies have further demonstrated that Chinese herbal medicine not only induces ferroptosis in tumor cells and suppresses tumor proliferation but also enhances the therapeutic efficacy of radiotherapy, targeted therapy, and immunotherapy, thereby improving overall treatment outcomes. This article reviews recent advances in research on Chinese herbal medicine-mediated modulation of ferroptosis in GC and discusses the potential molecular mechanisms underlying ferroptosis in this malignancy, aiming to provide a theoretical foundation for the development of precise diagnostic approaches and targeted therapeutic strategies. CONCLUSION: Studies indicate that Chinese herbal medicines targeting ferroptosis hold promising potential in GC therapy, not only laying a theoretical foundation for elucidating the pathogenesis of GC and establishing ferroptosis-targeted Chinese herbal medicine intervention strategies, but also opening new avenues for the clinical prevention and treatment of GC.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gao S, Wang H. Pharmacological mechanisms of traditional Chinese medicine in treating gastric cancer: a focus on the ferroptosis regulation. Front Pharmacol. 2026. PMID: 41668813. doi:10.3389/fphar.2025.1700849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。